Individual patient-versus literature-based meta-analysis of survival data: Time to event and event rate at a particular time can make a difference, an example based on head and neck cancer

被引:39
作者
Duchateau, L
Pignon, JP
Bijnens, L
Bertin, S
Bourhis, J
Sylvester, R
机构
[1] EORTC, B-1200 Brussels, Belgium
[2] Inst Gustave Roussy, Dept Radiotherapy, F-94805 Villejuif, France
[3] Inst Gustave Roussy, Dept Biostat, F-94805 Villejuif, France
来源
CONTROLLED CLINICAL TRIALS | 2001年 / 22卷 / 05期
关键词
literature-based meta-analysis; individual patient data meta-analysis; hazard ratio; odds ratio; head and neck cancer;
D O I
10.1016/S0197-2456(01)00152-0
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The objective of this study is to compare the result's of an individual patient-based and a literature-based meta-analysis in chemotherapy in head and neck cancer and to identify the sources of difference. For all head and neck cancer randomized controlled clinical trials comparing chemotherapy and loco-regional treatment with loco-regional treatment alone, both the literature data and the individual patient data are retrieved and meta-analyses performed and compared. Only survival data are used as outcome, although both time to death and mortality at specific time points are considered in different analyses. There are substantial differences between the individual patient-based and the literature-based meta-analyses. The most important reason for the differing results is that the individual patient-based meta-analysis is based on a time to event analysis, whereas the literature-based meta-analysis is based on mortality at a specific time point. Mortality can change substantially with follow-up time. The absolute survival differences in the case study, for instance, increase from 2.6% at 2 years to 5.6% at 5 years. Control Clin Trials 2001;22:538-547 (C) Elsevier Science Inc. 2001.
引用
收藏
页码:538 / 547
页数:10
相关论文
共 18 条
[1]   Meta-analyses in head and neck squamous cell carcinoma - What is the role of chemotherapy? [J].
Bourhis, J ;
Pignon, JP .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1999, 13 (04) :769-+
[2]   ISSUES OF EFFICIENCY IN COMBINING PROPORTIONS OF DEATHS FROM SEVERAL CLINICAL-TRIALS [J].
BUYSE, M ;
RYAN, LM .
STATISTICS IN MEDICINE, 1987, 6 (05) :565-576
[3]   Systematic reviews using individual patient data: A map for the minefields? [J].
Clarke, M ;
Godwin, J .
ANNALS OF ONCOLOGY, 1998, 9 (08) :827-833
[4]   Estimating number of events from the Kaplan-Meier curve for incorporation in a literature-based meta-analysis: What you don't see you can't get! [J].
Duchateau, L ;
Collette, L ;
Sylvester, R ;
Pignon, JP .
BIOMETRICS, 2000, 56 (03) :886-892
[5]   Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region: A meta-analysis of prospective and randomized trials [J].
ElSayed, S ;
Nelson, N .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) :838-847
[6]  
MANTEL N, 1959, J NATL CANCER I, V22, P719
[7]   AN OVERVIEW OF RANDOMIZED CONTROLLED TRIALS OF ADJUVANT CHEMOTHERAPY IN HEAD AND NECK-CANCER [J].
MUNRO, AJ .
BRITISH JOURNAL OF CANCER, 1995, 71 (01) :83-91
[8]   FROM SCIENCE TO PRACTICE - METAANALYSES USING INDIVIDUAL PATIENT DATA ARE NEEDED [J].
OXMAN, AD ;
CLARKE, MJ ;
STEWART, LA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (10) :845-846
[9]  
Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO
[10]  
2-8